317 related articles for article (PubMed ID: 34831420)
1. Mitochondrial Metabolism in Melanoma.
Huang C; Radi RH; Arbiser JL
Cells; 2021 Nov; 10(11):. PubMed ID: 34831420
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial oxidative phosphorylation in cutaneous melanoma.
Kumar PR; Moore JA; Bowles KM; Rushworth SA; Moncrieff MD
Br J Cancer; 2021 Jan; 124(1):115-123. PubMed ID: 33204029
[TBL] [Abstract][Full Text] [Related]
3. Metabolic flexibility in melanoma: A potential therapeutic target.
Ruocco MR; Avagliano A; Granato G; Vigliar E; Masone S; Montagnani S; Arcucci A
Semin Cancer Biol; 2019 Dec; 59():187-207. PubMed ID: 31362075
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of mitochondrial bioenergetics by polycations counteracts resistance to BRAF
Hall A; Maynard S; Wu LP; Merchut-Maya JM; Strauss R; Moghimi SM; Bartek J
J Control Release; 2019 Sep; 309():158-172. PubMed ID: 31348978
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial function in melanoma.
Theodosakis N; Micevic G; Kelly DP; Bosenberg M
Arch Biochem Biophys; 2014 Dec; 563():56-9. PubMed ID: 24997363
[TBL] [Abstract][Full Text] [Related]
6. CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human malignant melanoma cells.
Luo Z; Zeng W; Tang W; Long T; Zhang J; Xie X; Kuang Y; Chen M; Su J; Chen X
Curr Mol Med; 2014; 14(10):1252-64. PubMed ID: 25470292
[TBL] [Abstract][Full Text] [Related]
7. Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma.
Filipp FV; Ratnikov B; De Ingeniis J; Smith JW; Osterman AL; Scott DA
Pigment Cell Melanoma Res; 2012 Nov; 25(6):732-9. PubMed ID: 22846158
[TBL] [Abstract][Full Text] [Related]
8. Bromodomain-containing protein 4 inhibitor JQ1 promotes melanoma cell apoptosis by regulating mitochondrial dynamics.
Li L; Meng Y; Wu X; Li J; Sun Y
Cancer Sci; 2021 Oct; 112(10):4013-4025. PubMed ID: 34252226
[TBL] [Abstract][Full Text] [Related]
9. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
Zhang G; Frederick DT; Wu L; Wei Z; Krepler C; Srinivasan S; Chae YC; Xu X; Choi H; Dimwamwa E; Ope O; Shannan B; Basu D; Zhang D; Guha M; Xiao M; Randell S; Sproesser K; Xu W; Liu J; Karakousis GC; Schuchter LM; Gangadhar TC; Amaravadi RK; Gu M; Xu C; Ghosh A; Xu W; Tian T; Zhang J; Zha S; Liu Q; Brafford P; Weeraratna A; Davies MA; Wargo JA; Avadhani NG; Lu Y; Mills GB; Altieri DC; Flaherty KT; Herlyn M
J Clin Invest; 2016 May; 126(5):1834-56. PubMed ID: 27043285
[TBL] [Abstract][Full Text] [Related]
10. Molecular drivers of cellular metabolic reprogramming in melanoma.
Abildgaard C; Guldberg P
Trends Mol Med; 2015 Mar; 21(3):164-71. PubMed ID: 25618774
[TBL] [Abstract][Full Text] [Related]
11. Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors.
Marchetti P; Trinh A; Khamari R; Kluza J
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):999-1005. PubMed ID: 29413908
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation.
Haq R; Fisher DE; Widlund HR
Clin Cancer Res; 2014 May; 20(9):2257-63. PubMed ID: 24610826
[TBL] [Abstract][Full Text] [Related]
13. Metabolic features of melanoma: a gold mine of new therapeutic targets?
Marchetti P; Guerreschi P; Kluza J; Mortier L
Curr Cancer Drug Targets; 2014; 14(4):357-70. PubMed ID: 24720363
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine metabolism as a therapeutic target in cutaneous melanoma.
Dany M
Transl Res; 2017 Jul; 185():1-12. PubMed ID: 28528915
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells.
Bilska B; Schedel F; Piotrowska A; Stefan J; Zmijewski M; Pyza E; Reiter RJ; Steinbrink K; Slominski AT; Tulic MK; Kleszczyński K
J Pineal Res; 2021 Apr; 70(3):e12728. PubMed ID: 33650175
[TBL] [Abstract][Full Text] [Related]
18. Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors.
Khamari R; Trinh A; Gabert PE; Corazao-Rozas P; Riveros-Cruz S; Balayssac S; Malet-Martino M; Dekiouk S; Joncquel Chevalier Curt M; Maboudou P; Garçon G; Ravasi L; Guerreschi P; Mortier L; Quesnel B; Marchetti P; Kluza J
Cell Death Dis; 2018 Feb; 9(3):325. PubMed ID: 29487283
[TBL] [Abstract][Full Text] [Related]
19. SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.
Hüser L; Sachindra S; Granados K; Federico A; Larribère L; Novak D; Umansky V; Altevogt P; Utikal J
Int J Cancer; 2018 Dec; 143(12):3131-3142. PubMed ID: 29905375
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial chaperone, TRAP1 modulates mitochondrial dynamics and promotes tumor metastasis.
Purushottam Dharaskar S; Paithankar K; Kanugovi Vijayavittal A; Shabbir Kara H; Amere Subbarao S
Mitochondrion; 2020 Sep; 54():92-101. PubMed ID: 32784002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
